Last reviewed · How we verify
LASER assisted SRP
LASER assisted SRP is a Small molecule drug developed by SVS Institute of Dental Sciences. It is currently in Phase 2 development. Also known as: Control group.
LASER-assisted Scaling and Root Planing (SRP) has been studied for treating conditions such as periodontitis, periodontal disease, and periodontal pockets. The treatment involves the use of lasers, specifically Nd:YAG and Diode Lasers, which are protein modality agonists that target the follicle-stimulating hormone receptor.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | LASER assisted SRP |
|---|---|
| Also known as | Control group |
| Sponsor | SVS Institute of Dental Sciences |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Nd:YAG Laser Versus Diode Laser Assisted New Attachment Procedure (Lanap) in the Management of Stage II Periodontitis (NA)
- Adjunctive Diode Laser Therapy in Non-Surgical Periodontal Therapy (NA)
- Nd:YAG Laser Effects on Subgingival Microbiota in Stage III-IV Periodontitis (NA)
- the Clinical Effect of Nd: YAG Laser Assisted Periodontal Initial Therapy in Patients With Moderate to Severe Periodontitis (NA)
- Clinical and Microbiological Evaluation of Laser Assisted New Attachment Procedure (LANAP) Using Nd:Yag vs. Diode Laser in the Management Of Stage II Periodontitis (NA)
- YSGG Application in Periodontal Treatment (NA)
- Use of Laser Assisted New Attachment Procedure and Low Level Laser Therapy for Periodontitis Patients (NA)
- Novel Photosensitizer in The Treatment of Chronic Periodontitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LASER assisted SRP CI brief — competitive landscape report
- LASER assisted SRP updates RSS · CI watch RSS
- SVS Institute of Dental Sciences portfolio CI
Frequently asked questions about LASER assisted SRP
What is LASER assisted SRP?
Who makes LASER assisted SRP?
Is LASER assisted SRP also known as anything else?
What development phase is LASER assisted SRP in?
Related
- Manufacturer: SVS Institute of Dental Sciences — full pipeline
- Also known as: Control group
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing